TERI ROESSLER-KENNEDY: Open Payments
NPI 1598318024 · LIVE OAK, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$934 in 44 payments from 12 companies in 2025. Trend: 2023 $576 · 2024 $765 · 2025 $934
Food & beverage: $934
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 3 | $225 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 9 | $143 |
| Lilly USA, LLC | 8 | $138 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 5 | $100 |
| GlaxoSmithKline, LLC. | 6 | $90 |
| ABBVIE INC. | 4 | $80 |
| Novo Nordisk Inc | 3 | $56 |
| Exact Sciences Corporation | 2 | $29 |
| SANOFI-AVENTIS U.S. LLC | 1 | $25 |
| PFIZER INC. | 1 | $19 |
Products named: AIRSUPRA, CAPLYTA, JARDIANCE, MOUNJARO, TRELEGY ELLIPTA, Ozempic, QULIPTA, VRAYLAR.
Industry payments across FL — which companies pay providers there.
